MTP inhibitor decreases plasma cholesterol levels in LDL receptor-deficient WHHL rabbits by lowering the VLDL secretion

European Journal of Pharmacology

Volumn 431, Issue 1, 2001, Pages 127-131

  Shiomi, Masashi ^a   Ito, Takashi ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

Hypolipidemic effect; Implitapide; MTP inhibitor; Rabbit; VLDL (very low density lipoprotein) secretion; WHHL

Indexed keywords

2 CYCLOPENTYL 2 [4 [(2,4 DIMETHYL 9H PYRIDO[2,3 B]INDOL 9 YL)METHYL]PHENYL] N [2 HYDROXY 1 PHENYLETHYL]ETHANAMIDE; ALPHA TOCOPHEROL; LOW DENSITY LIPOPROTEIN; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN INHIBITOR; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILIAL HYPERLIPEMIA; HYPOLIPEMIA; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN SECRETION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

ANIMALS; CARRIER PROTEINS; CHOLESTEROL; CHOLESTEROL, LDL; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HYPERLIPOPROTEINEMIA TYPE II; INDOLES; LIPOPROTEINS, VLDL; LIVER; PYRIDINES; RABBITS; RECEPTORS, LDL; TRIGLYCERIDES; VITAMIN E;

EID: 0035834505     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01419-4     Document Type: Article

References (21)

1. The inhibition in vivo of lipoprotein lipase (clearing-factor lipase) activity by Triton WR-1339
2. Plasma clearance and net uptake of α-tocopherol and low-density lipoprotein by tissues in WHHL and control rabbits
3. A simple method for the isolation and purification of total lipids from animal tissues
4. Bay 13-9952 (Implitapide), an inhibitor of the microsomal triglyceride transfer protein (MTP), blocks secretion of apo-B-lipoproteins
5. Effects of chronic glucagons administration on rat lipoprotein composition
6. An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells
7. Deficiency of low density lipoprotein receptors in liver and adrenal gland of the WHHL rabbit, an animal model of familial hypercholesterolemia
8. Effects of pravastatin sodium alone and in combination with cholestyramine on hepatic, intestinal and adrenal low density lipoprotein receptors in homozygous Watanabe heritable hyperlipidemic rabbits
9. Protein measurement with Folin phenol reagent
10. Effect of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on triglyceride kinetics in chronically streptozotocin-diabetic rats
11. Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia
12. Pravastatin sodium, a competitive inhibitor of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase, decreased the cholesterol content of newly secreted very-low-density lipoprotein in Watanabe heritable hyperlipidemic rabbits
13. Inheritability of atherosclerosis and the role of lipoproteins as risk factors in the development of atherosclerosis in WHHL rabbits: Risk factors related to coronary atherosclerosis are different from those related to aortic atherosclerosis
14. Effect of fluvastatin sodium on secretion of very low density lipoprotein and serum cholesterol levels
15. A non-parametric equivalent of Williams' test for containing increasing dose level of a treatment
16. Effect of Triton on lipoprotein lipase of rat plasma
17. Implitapide
18. WHHL-rabbit: A low density lipoprotein receptor-deficient animal model for familial hypercholesterolemia
19. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia
20. An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits
21. Effect of low density lipoprotein receptor deficiency on the metabolism of apolipoprotein B-100 in blood plasma